PTC THERAPEUTICS, INC. — Director's Dealing 2017

Jun 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2017-05-31

Reporting Person: Souza Marcio (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-31	Common Stock	A	30000	—	Acquired	36457	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-31	Stock Option (Right To Buy)	$12.53	A	30000	Acquired	2017-05-31	Common Stock (30000.0)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right To Buy)	$26.42	2024-07-31	Common Stock (30000.0)	30000	Direct
Stock Option (Right To Buy)	$51.0	2025-01-02	Common Stock (10525.0)	10525	Direct
Stock Option (Right To Buy)	$30.86	2026-01-03	Common Stock (16000.0)	16000	Direct
Stock Option (Right To Buy)	$12.64	2026-11-16	Common Stock (2000.0)	2000	Direct
Stock Option (Right To Buy)	$11.23	2027-01-02	Common Stock (23100.0)	23100	Direct
Stock Option (Right To Buy)	$12.92	2027-05-17	Common Stock (10000.0)	10000	Indirect

Footnotes

F1: Restricted stock awarded to the Reporting Person vests in two equal annual installments over two years, commencing on May 31, 2018.

F2: This option was granted on May 31, 2017, and vests in two equal annual installments over two years, commencing on May 31, 2018.

F3: This option was granted on July 31, 2014 and vests over four years, with 25% of the shares underlying the option vested on July 31, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 31, 2015.

F4: This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on January 2, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2016.

F5: This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.

F6: This option was granted on November 17, 2016, and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.

F7: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.

F8: This option was granted on May 17, 2017, and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018.